Advanced search
Publication Cover
Modern Rheumatology Volume 29, 2019 - Issue 5
Journal homepage
299
Views
12
CrossRef citations to date
0
Altmetric
Original Article

The three-year efficacy of iguratimod in clinical daily practice in patients with rheumatoid arthritis

Takahito SutoDepartment of Orthopaedic Surgery, Gunma University Graduate School of Medicine, Gunma, Japan; Correspondence[email protected]
,
Yukio YonemotoDepartment of Orthopaedic Surgery, Gunma University Graduate School of Medicine, Gunma, Japan;
,
Koichi OkamuraDepartment of Orthopaedic Surgery, Gunma University Graduate School of Medicine, Gunma, Japan;
,
Hideo SakaneDepartment of Orthopaedic Surgery, Gunma University Graduate School of Medicine, Gunma, Japan;
,
Kimihiko TakeuchiDepartment of Rheumatology, Isesaki Fukushima Hospital, Gunma, Japan;
,
Yasuyuki TamuraDepartment of Orthopaedic Surgery, Inoue Hospital, Gunma, Japan;
,
Tetsuya KanekoDepartment of Orthopaedic Surgery, Japan Redcross Society Fukaya Redcross Hospital, Saitama, Japan;
,
Keio AyabeDepartment of Orthopaedic Surgery, Keiyu Orthopaedic Hospital, Gunma, Japan
&
Hirotaka ChikudaDepartment of Orthopaedic Surgery, Gunma University Graduate School of Medicine, Gunma, Japan;
show all
Pages 775-781 | Received 11 Jun 2018, Accepted 31 Jul 2018, Published online: 20 Dec 2018

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Naoki Ishiguro, Kai Shibata, Akiko Yoshimura, Satoshi Ikeuchi & Mika Ishii. (2020) Investigation of the predictors of the response to Iguratimod therapy: A post-hoc analysis of post-marketing surveillance study. Modern Rheumatology 30:4, pages 626-632.
Read now
Yuji Nozaki, Asuka Inoue, Koji Kinoshita, Masanori Funauchi & Itaru Matsumura. (2020) Efficacy of iguratimod vs. salazosulfapyridine as the first-line csDMARD for rheumatoid arthritis. Modern Rheumatology 30:2, pages 249-258.
Read now

Articles from other publishers (10)

Liuting Zeng, Qi He, Ying Deng, Yuwei Li, Junpeng Chen, Kailin Yang, Yanfang Luo, Anqi Ge, Xiaofei Zhu, Zhiyong Long & Lingyun Sun. (2023) Efficacy and safety of iguratimod in the treatment of rheumatic and autoimmune diseases: a meta-analysis and systematic review of 84 randomized controlled trials. Frontiers in Pharmacology 14.
Crossref
Liuting Zeng, Qi He, Kailin Yang, Wensa Hao, Ganpeng Yu & Hua Chen. (2022) A Systematic Review and Meta-Analysis of 19 Randomized Controlled Trials of Iguratimod Combined With Other Therapies for Sjogren’s Syndrome. Frontiers in Immunology 13.
Crossref
Liuting Zeng, Ganpeng Yu, Kailin Yang, Wensa Hao & Hua Chen. (2022) The Effect and Safety of Iguratimod Combined With Methotrexate on Rheumatoid Arthritis: A Systematic Review and Meta-Analysis Based on a Randomized Controlled Trial. Frontiers in Pharmacology 12.
Crossref
Sajan Shrestha, Jing Zhao, Changqing Yang & Jinping Zhang. (2021) Iguratimod combination therapy compared with methotrexate monotherapy for the treatment of rheumatoid arthritis: a systematic review and meta-analysis. Clinical Rheumatology 40:10, pages 4007-4017.
Crossref
Sha Liu, Li-Ping Song, Rong-Bin Li, Le-Heng Feng & Hui Zhu. (2021) Iguratimod promotes transformation of mononuclear macrophages in elderly patients with rheumatoid arthritis by nuclear factor-κB pathway. World Journal of Clinical Cases 9:10, pages 2181-2191.
Crossref
Chang-hong Li, Zhen-zhen Ma, Lei-lei Jian, Xin-yu Wang, Lin Sun, Xiang-yuan Liu, Zhong-qiang Yao & Jin-xia Zhao. (2021) Iguratimod inhibits osteoclastogenesis by modulating the RANKL and TNF-α signaling pathways. International Immunopharmacology 90, pages 107219.
Crossref
Asuka Inoue, Yuji Nozaki, Yasuaki Hirooka, Koji Kinoshita, Yasutaka Chiba, Masanori Funauchi & Itaru Matsumura. (2020) The Effectiveness and Retention Rate of Iguratimod in Japanese Rheumatoid Arthritis Patients with/without Methotrexate in Daily Medical Care. Life 10:11, pages 261.
Crossref
Sisi Xie, Shu Li, Jing Tian & Fen Li. (2020) Corrigendum: Iguratimod as a New Drug for Rheumatoid Arthritis: Current Landscape. Frontiers in Pharmacology 11.
Crossref
Sisi Xie, Shu Li, Jing Tian & Fen Li. (2020) Iguratimod as a New Drug for Rheumatoid Arthritis: Current Landscape. Frontiers in Pharmacology 11.
Crossref
Charalampos Skarlis, Nikolaos Marketos & Clio P. Mavragani. (2019) Biologics in Sjögren's syndrome. Pharmacological Research 147, pages 104389.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.